FICCX | FTCNX | FICCX / FTCNX | |
Total Expense Ratio | 1.04 | 1.57 | 66% |
Annual Report Gross Expense Ratio | 1.04 | 1.57 | 66% |
Fund Existence | 18 years | 18 years | - |
Gain YTD | 14.382 | 14.110 | 102% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 996M | 996M | 100% |
Annual Yield % from dividends | 1.39 | 0.68 | 206% |
Returns for 1 year | 13.40 | 12.77 | 105% |
Returns for 3 years | 17.42 | 15.39 | 113% |
Returns for 5 years | 65.93 | 61.70 | 107% |
Returns for 10 years | 59.05 | 54.87 | 108% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 19.76 | 0.18 | +0.91% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
OPP | 8.42 | 0.01 | +0.12% |
RiverNorth/DoubleLine Strategic Opportunity Fund | |||
DEED | 20.92 | -0.02 | -0.10% |
First Trust Securitized Plus ETF | |||
ILTB | 48.34 | -0.11 | -0.23% |
iShares Core 10+ Year USD Bond ETF | |||
UTG | 34.55 | -0.20 | -0.58% |
Reaves Utility Income Fund |